⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Daniela Rohne-GarlapatiD.O., MPH

Internal Medicine · Cambridge, MA 02139

NPI: 1093985467

Share:

31

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers95th percentile opioid prescribing

Risk indicators are statistical patterns, not allegations. Learn more

101

Total Claims

$5,589

Drug Cost

69

Beneficiaries

$81

Cost/Patient

Risk Score Breakdown 31/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+6

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+2642%

Opioid rate vs peers

61.4% vs 2.2% avg

-94%

Cost per patient vs peers

$81 vs $1,411 avg

+133%

Brand preference vs peers

24.8% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 2,642% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

61.4%

Opioid Rate

62

Opioid Claims

$245

Opioid Cost

Long-Acting Rate

This provider's opioid prescribing rate of 61.4% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

75% generic

Brand: 25 claims · $4,763

Generic: 76 claims · $827

Patient Profile

73

Avg Age

46%

Female

0.80

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About